KR20240001172A - 중간엽 계통 전구체 또는 줄기 세포를 이용하는 급성 호흡 곤란 증후군(ards)의 치료 방법 - Google Patents

중간엽 계통 전구체 또는 줄기 세포를 이용하는 급성 호흡 곤란 증후군(ards)의 치료 방법 Download PDF

Info

Publication number
KR20240001172A
KR20240001172A KR1020237039592A KR20237039592A KR20240001172A KR 20240001172 A KR20240001172 A KR 20240001172A KR 1020237039592 A KR1020237039592 A KR 1020237039592A KR 20237039592 A KR20237039592 A KR 20237039592A KR 20240001172 A KR20240001172 A KR 20240001172A
Authority
KR
South Korea
Prior art keywords
subject
cells
ards
stem cells
mlpscs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237039592A
Other languages
English (en)
Korean (ko)
Inventor
실비우 이떼스쿠
Original Assignee
메조블라스트 인터내셔널 에스에이알엘
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2021901214A external-priority patent/AU2021901214A0/en
Application filed by 메조블라스트 인터내셔널 에스에이알엘 filed Critical 메조블라스트 인터내셔널 에스에이알엘
Publication of KR20240001172A publication Critical patent/KR20240001172A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
KR1020237039592A 2021-04-23 2022-04-22 중간엽 계통 전구체 또는 줄기 세포를 이용하는 급성 호흡 곤란 증후군(ards)의 치료 방법 Pending KR20240001172A (ko)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
AU2021901214A AU2021901214A0 (en) 2021-04-23 Method for treating acute respiratory distress syndrome (ARDS) using mesenchymal lineage precursor or stem cells
AU2021901214 2021-04-23
AU2021902180 2021-07-15
AU2021902180A AU2021902180A0 (en) 2021-07-15 Method for treating acute respiratory distress syndrome (ARDS) using mesenchymal lineage precursor or stem cells
AU2022900260 2022-02-09
AU2022900260A AU2022900260A0 (en) 2022-02-09 Method for treating acute respiratory distress syndrome (ARDS) in specific patients using mesenchymal lineage precursor or stem cells
AU2022900372 2022-02-18
AU2022900372A AU2022900372A0 (en) 2022-02-18 Method for treating acute respiratory distress syndrome (ARDS) using mesenchymal lineage precursor or stem cells
PCT/IB2022/053763 WO2022224207A1 (en) 2021-04-23 2022-04-22 Method for treating acute respiratory distress syndrome (ards) using mesenchymal lineage precursor or stem cells

Publications (1)

Publication Number Publication Date
KR20240001172A true KR20240001172A (ko) 2024-01-03

Family

ID=81585202

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020237039592A Pending KR20240001172A (ko) 2021-04-23 2022-04-22 중간엽 계통 전구체 또는 줄기 세포를 이용하는 급성 호흡 곤란 증후군(ards)의 치료 방법
KR1020237039593A Pending KR20240001173A (ko) 2021-04-23 2022-04-22 중간엽 계통 전구체 또는 줄기 세포를 이용하는 특정 환자의 급성 호흡 곤란 증후군(ards)의 치료 방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020237039593A Pending KR20240001173A (ko) 2021-04-23 2022-04-22 중간엽 계통 전구체 또는 줄기 세포를 이용하는 특정 환자의 급성 호흡 곤란 증후군(ards)의 치료 방법

Country Status (8)

Country Link
US (2) US20240207323A1 (https=)
EP (2) EP4326294A1 (https=)
JP (2) JP2024516172A (https=)
KR (2) KR20240001172A (https=)
AU (2) AU2022261504A1 (https=)
BR (2) BR112023021840A2 (https=)
CA (2) CA3216129A1 (https=)
WO (2) WO2022224206A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120087868A1 (en) 2010-10-08 2012-04-12 Gabriele Todd Nanoparticle-loaded cells
SG11202004680UA (en) 2017-11-22 2020-06-29 Mesoblast Int Sarl Cellular compositions and methods of treatment i

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US6251295B1 (en) 1998-01-08 2001-06-26 Nexell Therapeutics Inc. Method for recirculation washing of blood cells
BR112021024310A2 (pt) * 2019-06-05 2022-02-15 Univ Emory Peptidomiméticos para o tratamento de infecções por coronavírus e picornavírus

Also Published As

Publication number Publication date
BR112023021825A2 (pt) 2024-02-06
JP2024516173A (ja) 2024-04-12
US20240197787A1 (en) 2024-06-20
CA3216129A1 (en) 2022-10-27
JP2024516172A (ja) 2024-04-12
WO2022224207A1 (en) 2022-10-27
EP4326294A1 (en) 2024-02-28
AU2022260822A1 (en) 2023-11-30
EP4326295A1 (en) 2024-02-28
KR20240001173A (ko) 2024-01-03
US20240207323A1 (en) 2024-06-27
AU2022261504A1 (en) 2023-11-30
CA3216121A1 (en) 2022-10-27
WO2022224206A1 (en) 2022-10-27
BR112023021840A2 (pt) 2024-02-06

Similar Documents

Publication Publication Date Title
KR20220164741A (ko) 중간엽 계통 전구세포 또는 줄기세포를 이용한 과염증 치료 방법
US20230104108A1 (en) Method for treating inflammatory bowel disease ii
JP2023513847A (ja) 慢性移植片対宿主病の治療方法
US20240207323A1 (en) Method for treating acute respiratory distress syndrome (ards) using mesenchymal lineage precursor or stem cells
US20230293589A1 (en) Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells
US20230172991A1 (en) Method for treating inflammatory bowel disease i
JP2024500698A (ja) クラスｉｉ心不全を有する対象における進行性心不全を治療する方法
WO2023119239A1 (en) Method of treating severe graft versus host disease
CN117337184A (zh) 使用间充质谱系前体细胞或干细胞治疗急性呼吸窘迫综合征(ards)的方法
AU2024332651A1 (en) Third line treatment for gvhd
KR20260061190A (ko) GvHD에 대한 3차 치료
CN121985953A (en) Three-wire therapy for the treatment of GvHD

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20231116

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20250421

Comment text: Request for Examination of Application